|
MechanismTubulin inhibitors |
|
|
|
|
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismGnRHR antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Veru Healthcare, Inc.
0 Patents (Medical) associated with Veru Healthcare, Inc.
100 Deals associated with Veru Healthcare, Inc.
100 Translational Medicine associated with Veru Healthcare, Inc.